Bausch Christoph Lawrence has filed 3 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 1800000 shares of SAB Biotherapeutics, Inc. ($SABS) on February 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | SAB Biotherapeutics, Inc. | $SABS | Bausch Christoph Lawrence | CHIEF OPERATING OFFICER | A | Stock option (right to buy) | 1800000 | $0.00 | 1,800,000.0000 | 77,863,263 | 9999.99% | 2.31% |
| Aug. 26, 2025 | SAB Biotherapeutics, Inc. | $SABS | Bausch Christoph Lawrence | CHIEF OPERATING OFFICER | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 9,261,918 | 9999.99% | 6.48% |
| Feb. 21, 2024 | SAB Biotherapeutics, Inc. | $SABS | Bausch Christoph Lawrence | CHIEF OPERATING OFFICER | A | Employee Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 5,521,487 | 9999.99% | 2.54% |